Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hemorrhage × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 2 CNS 2 Sarcoma 1 Other hematologic neoplasm 1 Myeloid 1 Gastrointestinal 1

Conditions

Sarcoma 68 Gastrointestinal Stromal Tumors 32 Glioblastoma 19 Gliosarcoma 18 Dendritic Cell Sarcoma, Interdigitating 17 Neoplasms 16 Liposarcoma 16 Bone Neoplasms 16 Rhabdomyosarcoma 14 Neoplasm Metastasis 14 Leiomyosarcoma 14 Lymphoma, Large B-Cell, Diffuse 13 Burkitt Lymphoma 13 Central Nervous System Neoplasms 12 Sarcoma, Synovial 11 Recurrence 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Histiocytoma, Malignant Fibrous 11 Osteosarcoma 10 Lymphoma 10 Hemangiosarcoma 10 Fibrosarcoma 10 Brain Neoplasms 10 Multiple Myeloma 9 Lymphoma, Non-Hodgkin 9 Lymphoma, Mantle-Cell 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, Follicular 9 Lymphoma, B-Cell, Marginal Zone 9 Leukemia, Myeloid, Chronic-Phase 9

Interventions

Tranexamic Acid 1 Fibrin Tissue Adhesive 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡